sr141716 has been researched along with angiotensin ii in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Castro, LM; Dale, CS; de Souza, LL; Devi, LA; Ferro, ES; Giorgi, R; Gomes, I; Gupta, A; Heimann, AS; Luchessi, AD; Pagano, RL; Rioli, V | 1 |
Bátkai, S; Bukoski, RD; Harvey-White, J; Kunos, G; Liu, J; Mackie, K; Offertáler, L; Osei-Hyiaman, D; Pacher, P; Radaeva, S; Rudd, MA | 1 |
Balla, A; Catt, KJ; Hunyady, L; Nádasy, GL; Soltész-Katona, E; Szekeres, M; Tóth, ZE; Turu, G | 1 |
Isin, EM; Jurva, U; Thorsell, A | 1 |
4 other study(ies) available for sr141716 and angiotensin ii
Article | Year |
---|---|
Hemopressin is an inverse agonist of CB1 cannabinoid receptors.
Topics: Cell Line; Drug Inverse Agonism; Hemoglobins; Humans; Ligands; Peptide Fragments; Receptor, Cannabinoid, CB1 | 2007 |
Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.
Topics: Amidohydrolases; Angiotensin II; Animals; Arachidonic Acids; Benzamides; Benzyl Compounds; Blood Pressure; Camphanes; Carbamates; Dronabinol; Endocannabinoids; Endothelium, Vascular; Hypertension; Male; Models, Cardiovascular; Myocardial Contraction; Myocardium; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Inbred Dahl; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Up-Regulation; Vascular Resistance; Vasodilation; Ventricular Function, Left | 2004 |
Angiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 cannabinoid receptors.
Topics: Analgesics; Angiotensin II; Animals; Arteries; Benzoxazines; Endocannabinoids; Endothelium, Vascular; Hypertension; Male; Mice; Mice, Knockout; Morpholines; Muscle, Skeletal; Naphthalenes; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Vasoconstriction | 2012 |
Use of electrochemical oxidation and model peptides to study nucleophilic biological targets of reactive metabolites: the case of rimonabant.
Topics: Amino Acid Sequence; Angiotensin II; Animals; Cattle; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Electrochemical Techniques; Enkephalin, Leucine-2-Alanine; Humans; Microsomes, Liver; Oxidation-Reduction; Peptides; Piperidines; Pyrazoles; Rimonabant; Serum Albumin, Bovine; Tandem Mass Spectrometry | 2014 |